The relationship between take-away methadone policies and methadone diversion

References

• Farrell M. Methadone maintenance treatment in opiate dependence: a review. BMJ 1994; 309: 997–1001
   PubMed Web of Science ®Google Scholar
• Rhoades H M, Creson D, Elk R, Schmitz J, Grabowski J. Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health 1998; 88: 34–39
   PubMed Web of Science ®Google Scholar
• Cairns A, Roberts I, Benbow E. Characteristics of fatal methadone overdose in Manchester, 1985 – 1994. BMJ 1996; 313: 264–265
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Hall W. Prevalence and correlates of the injection of methadone syrup in Sydney, Australia. Drug Alcohol Depend 1996; 43: 191–198
   PubMed Web of Science ®Google Scholar
• Lintzeris N, Lenne M, Ritter A. Methadone injecting in Australia: a tale of two cities. Addiction 1999; 94: 1175–1178
   PubMed Web of Science ®Google Scholar
• Seymour A, Black M, Jay J, Cooper G, Weir C, Oliver J. The role of methadone in drug-related deaths in the west of Scotland. Addiction 2003; 98: 995–1002
   PubMed Web of Science ®Google Scholar
• Vormfelde S V, Poser W. Death attributed to methadone. Pharmacopsychiatry 2001; 34: 217–222
   PubMed Web of Science ®Google Scholar
• Heinemann A, Iwersen-Bergmann S, Stein S, Schmoldt A, Puschel K. Methadone-related fatalities in Hamburg 1990 – 1999: implications for quality standards in maintenance treatment?. Forensic Sci Int 2000; 113: 449–455
   PubMed Web of Science ®Google Scholar
• Hopwood M, Southgate E, Kippax S, Bammer G, Isaac-Toua G, MacDonald M. The injection of methadone syrup in New South Wales: patterns of use and increased harm after partial banning of injecting equipment. Aust NZ J Public Health 2003; 27: 551–555
   PubMed Web of Science ®Google Scholar
• Stone E, Fletcher K. User views on supervised methadone consumption. Addict Biol 2003; 8: 45–48
   PubMed Web of Science ®Google Scholar
• Pani P P, Pirastu R, Ricci A, Gessa G L. Prohibition of take-home dosages: negative consequences on methadone maintenance treatment. Drug Alcohol Depend 1996; 41: 81–84
   PubMed Web of Science ®Google Scholar
• Chutuape M A, Silverman K, Stitzer M L. Effects of urine testing frequency on outcome in a methadone take-home contingency program. Drug Alcohol Depend 2001; 62: 69–76
   PubMed Web of Science ®Google Scholar
• Robles E, Miller F B, Gilmore-Thomas K K, McMillan D E. Implementation of a clinic policy of client-regulated methadone dosing. J Subst Abuse Treat 2001; 20: 225–230
   PubMed Web of Science ®Google Scholar
• Ali R L, Quigley A J. Accidental drug toxicity associated with methadone maintenance treatment: as patient tolerance varies widely, methadone prescribers and users need to be better informed about the risks of overdose. Med J Aust 1998; 170: 100–191
   Google Scholar
• Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mount Sinai J Med 2000; 67: 347–364
   PubMed Web of Science ®Google Scholar
• Southgate E, Kippax S, Bammer G, et al. Methadone injection in NSW. National Centre in HIV Social Research, National Centre for Epidemiology and Population Health, National Centre in HIV Epidemiology and Clinical Research, Sydney 2001
   Google Scholar
• Spunt B, Hunt D E, Lipton D S, Goldsmith D S. Methadone diversion: new look. J Drug Issues 1986; 16: 569–583
   Web of Science ®Google Scholar
• Sunjic S, Zador D. Methadone syrup-related deaths in New South Wales, Australia, 1990 – 1995. Drug Alcohol Rev 1999; 18: 409–415
   Web of Science ®Google Scholar
• Swensen G. Opioid drug deaths in Western Australia: 1974 – 1984. Aust Drug Alcohol Rev 1988; 7: 181–185
   Google Scholar
• Humeniuk R, Ali R, McGregor C, Darke S. Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia. Addiction 2003; 98: 413–418
   PubMed Web of Science ®Google Scholar
• Topp L, Kaye S, Bruno R, et al. Australian drug trends 2001: findings from the Illicit Drug Reporting System (IDRS) NDARC monograph report no. 48, National Drug and Alcohol Research Centre, Sydney 2002
   Google Scholar
• Bruno R, McLean S. Tasmanian drug trends: findings from the Illicit Drug Reporting System (IDRS). NDARC technical report no. 135. National Drug and Alcohol Research Centre, Sydney 2002
   Google Scholar
• Fry C, Miller P. Victorian drug trends 2001: findings from the Illicit Drug Reporting System. NDARC technical report no. 129. National Drug and Alcohol Research Centre, Sydney 2002
   Google Scholar
• Hargreaves K, Lenton S. WA drug trends 2001: findings from the Illicit Drug Reporting System (IDRS). NDARC technical report no. 134. National Drug and Alcohol Research Centre, Sydney 2002
   Google Scholar
• Longo M, Humeniuk R, Christie P, Ali R. SA drug trends 2001: findings from the Illicit Drug Reporting System (IDRS). NDARC technical report no. 130. National Drug and Alcohol Research Centre, Sydney 2002
   Google Scholar
• Rose G M, Najman J M. Qld drug trends 2001: findings from the Illicit Drug Reporting System (IDRS). NDARC technical report no. 132. National Drug and Alcohol Research Centre, Sydney 2002
   Google Scholar
• Dietze P, Fitzgerald J. Interpreting changes in heroin supply in Melbourne: droughts, gluts or cycles?. Drug Alcohol Rev 2002; 21: 295–303
   PubMed Web of Science ®Google Scholar
• Weatherburn D, Jones C, Freeman K, Makkai T. Supply control and harm reduction: lessons from the Australian heroin ‘drought’. Addiction 2003; 98: 83–91
   PubMed Web of Science ®Google Scholar
• Darke S, Kaye S, Topp L. NSW drug trends 2001: findings from the Illicit Drug Reporting System (IDRS). NDARC technical report no. 125. National Drug and Alcohol Research Centre, Sydney 2002
   Google Scholar
• Sorensen J L, Guydish J, Gleghorn A, et al. Evaluation of treatment on demand in San Francisco: qualitative methods illuminate waiting list data. 64th Annual Scientific Meeting, College on Problems of Drug Dependence. Quebec City, Canada 2002, Drug Alcohol Depend 2002; 66(Supplement 1): S168 – 9.
   Google Scholar
• Brands B, Blake J, Marsh D. Changing patient characteristics with increased methadone maintenance availability. Drug Alcohol Depend 2002; 66: 11–20
   PubMed Web of Science ®Google Scholar
• Jenkinson R, Fry C, Miller P. Victorian drug trends 2002: findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre Technical Report no. 145. National Drug and Alcohol Research Centre, Sydney 2003
   Google Scholar